Global Patent Index - EP 2682114 A1

EP 2682114 A1 20140108 - Milnacipran for the long-term treatment of fibromyalgia syndrome

Title (en)

Milnacipran for the long-term treatment of fibromyalgia syndrome

Title (de)

Milnacipran für die Langzeitbehandlung des Fibromyalgie-Syndroms

Title (fr)

Milnacipran pour le traitement a long terme du syndrome de la fibromyalgie

Publication

EP 2682114 A1 20140108 (EN)

Application

EP 13187396 A 20060927

Priority

  • US 72172205 P 20050928
  • EP 06804211 A 20060927
  • US 2006037714 W 20060927

Abstract (en)

The present invention is directed to methods for providing long-term treatment of fibromyalgia syndrome (FMS) by administering a composition comprising milnacipran and a second active compound to a patient with FMS. More particularly, the present invention is directed to the long-term treatment of FMS by administering milnacipran combined with pregabalin to a patient with FMS.

IPC 8 full level

A61K 31/165 (2006.01); A61K 31/197 (2006.01); A61K 45/06 (2006.01); A61P 19/02 (2006.01); A61P 25/04 (2006.01)

CPC (source: EP KR US)

A61K 31/165 (2013.01 - EP KR US); A61K 31/197 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 1/00 (2017.12 - EP); A61P 1/04 (2017.12 - EP); A61P 3/00 (2017.12 - EP); A61P 13/00 (2017.12 - EP); A61P 13/02 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 21/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/04 (2017.12 - EP); A61P 25/06 (2017.12 - EP); A61P 25/20 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 43/00 (2017.12 - EP)

C-Set (source: EP US)

  1. A61K 31/165 + A61K 2300/00
  2. A61K 31/197 + A61K 2300/00

Citation (applicant)

  • US 6602911 B2 20030805 - KRANZLER JAY D [US], et al
  • US 67876703 A 20031003
  • WOLFE ET AL., ARTHRITIS RHEUM., vol. 33, no. 2, 1990, pages 160 - 172
  • WOLFE ET AL., ARTHRITIS RHEUM., vol. 38, no. 1, 1995, pages 19 - 28
  • CLAUW DJ; CHROUSOS GP, NEUROIMMUNOMODULATION, vol. 4, no. 3, 1997, pages 134 - 153
  • YUNAS MB, J RHEUMATOL., vol. 19, no. 6, 1992, pages 846 - 850
  • BRADLEY ET AL., CURR RHEUMATOL REP, vol. 2, no. 2, 2000, pages 141 - 148
  • SIMMS RW, AM J MED SCI., vol. 315, no. 6, 1998, pages 346 - 350
  • MOUNTZ ET AL., ARTHRITIS & RHEUMATISM, vol. 38, no. 7, 1995, pages 926 - 938
  • ARROYO JF; COHEN ML, J RHEUNATOL., vol. 20, no. 11, 1993, pages 1925 - 1931
  • SINDRUP SH; TS JENSEN, PAIN, vol. 83, no. 3, 1999, pages 389 - 400
  • WOOLF CJ, NATURE, vol. 306, no. 5944, 1983, pages 686 - 688
  • WOOLF CJ; RJ MANNION, LANCET, vol. 353, no. 9168, 1999, pages 1959 - 1964
  • MUKERJI ET AL., ANGIOLOGY, vol. 46, no. 5, 1995, pages 425 - 430
  • FREEMAN R; KOMAROFF AL, AM J MED., vol. 102, no. 4, 1997, pages 357 - 364
  • LURIE ET AL., SCAND J REHAB MED., vol. 22, no. 3, 1990, pages 151 - 155
  • PELLEGRINO ET AL., ARCH PHYS MED REHAB., vol. 70, no. 7, 1989, pages 541 - 543
  • ROWE ET AL., LANCET, vol. 345, no. 8950, 1995, pages 623 - 624
  • FELSON ET AL., ARTHRITIS RHEUM., vol. 36, no. 6, 1993, pages 729 - 740
  • FELSON DT, J RHEUMATOL., vol. 20, no. 3, 1993, pages 581 - 534
  • BUSKILA D, BAILLIERES BEST PRACT RES CLIN RHEUMATOL., vol. 13, no. 3, 1999, pages 479 - 485
  • LEVENTHAL LJ, ANN INTERN MED., vol. 131, no. 1 1, 1999, pages 850 - 858
  • LAUTENSCHLAGER J; SCAND J, RHEUMATOL, vol. 113, 2000, pages 32 - 36
  • WOLFE ET AL., ARTHRITIS RHEUM., vol. 40, no. 9, 1997, pages 1571 - 1579
  • GOLDENBERG ET AL., ARTHRITIS RHEUM., vol. 29, no. 11, 1986, pages 1371 - 1377
  • YUNUS ET AL., J RHEUMATOL., vol. 16, no. 4, 1989, pages 527 - 532
  • WOLFE ET AL., ARTHRITIS RHEUM., vol. 43, no. 2, 2000, pages 378 - 385
  • RUSSELL ET AL., ARTHRITIS RHEUM., vol. 34, no. 5, 1991, pages 552 - 560
  • QUIJADA-CARRERA ET AL., PAIN, vol. 65, no. 2- 3, 1996, pages 221 - 225
  • SINDRUP SH; JENSEN TS, PAIN, vol. 83, no. 3, 1999, pages 389 - 400
  • BENNETT RM, J FUNCTIONAL SYNDROMES, vol. 1, no. 1, 2001, pages 79 - 92
  • LAUTENSCHLAGER J, SCAND J RHEUMATOL SUPPL., vol. 113, 2000, pages 32 - 36
  • KOBAYASHI ET AL., EUR J PHA[PI]NACOL., vol. 31 1, no. 1, 1996, pages 29 - 35
  • KENT JM, LANCET, vol. 355, no. 9207, 2000, pages 911 - 918
  • MAX ET AL., NEUROLOGY, vol. 38, no. 9, 1988, pages 1427 - 1432
  • MAX ET AL., N ENG J MED., vol. 326, no. 19, 1992, pages 1250 - 1256
  • WATSON ET AL., NEUROLOGY, vol. 32, no. 6, 1982, pages 671 - 673
  • WATSON ET AL., PAIN, vol. 48, no. 1, 1992, pages 29 - 36
  • HANNONEN ET AL., BR J RHEUMATOL., vol. 37, no. 12, 1998, pages 1279 - 1286
  • GOLDENBERG ET AL., ARTHRITIS & RHEUMATISM, vol. 39, no. 11, 1996, pages 1852 - 1859
  • WOLFE ET AL., SCAND J RHEUM., vol. 23, no. 5, 1994, pages 255 - 259
  • ANDERBERG ET AL., EUR J PAIN, vol. 4, no. 1, 2000, pages 27 - 35
  • NORREGAARD ET AL., PAIN, vol. 61, no. 3, 1995, pages 445 - 449
  • MAX ET AL., N ENGL J MED., vol. 326, no. 19, 1992, pages 1250 - 1256
  • ANSARI A, HARV REV PSYCH., vol. 7, no. 5, 2000, pages 257 - 277
  • ATKINSON ET AL., PAIN, vol. 83, no. 2, 1999, pages 137 - 145
  • JUNG ET AL., J GEN INTERN MED., vol. 12, no. 6, 1997, pages 384 - 389
  • SAPER ET AL., HEADACHE, vol. 41, no. 5, 2001, pages 465 - 474
  • SANCHEZ C; HYTELL J, CELL MOL NEUROBIOL., vol. 19, no. 4, 1999, pages 467 - 489
  • DWIGHT ET AL., PSYCHOSOMATICS, vol. 39, no. 1, 1998, pages 14 - 17
  • DUALE ET AL., NEUROREPORT, vol. 12, no. 10, 2001, pages 2091 - 2096
  • BESSE ET AL., BRAIN RES., vol. 521, no. 1-2, 1990, pages 15 - 22
  • FIELDS ET AL., NATURE, vol. 306, no. 5944, 1983, pages 684 - 686
  • YAKSH ET AL., PROC NATL ACAD SCI USA, vol. 96, no. 14, 1999, pages 7680 - 7686
  • BENNETT RM, MAYO CLIN PROC., vol. 74, no. 4, 1999, pages 385 - 398
  • CARETTE ET AL., ARTHRITIS & RHEUMATISM, vol. 37, no. 1, 1994, pages 32 - 40
  • GRARD ET AL., ELECTROPHORESIS, vol. 21, 2000, pages 3028 - 3034
  • ZELTSER ET AL., PAIN, vol. 89, 2000, pages 19 - 24
  • BENNETT ET AL., PAIN, vol. 33, 1988, pages 87 - 107
  • SELTZER ET AL., PAIN, vol. 43, 1990, pages 205 - 218
  • KIM ET AL., PAIN, vol. 50, 1992, pages 355 - 363
  • DECOSTERD ET AL., PAIN, vol. 87, 2000, pages 149 - 158
  • JASMIN ET AL., PAIN, vol. 75, 1998, pages 367 - 382
  • QUINTERO ET AL., PHARMACOLOGY, BIOCHEMISTRY AND BEHAVIOR, vol. 67, 2000, pages 449 - 458

Citation (search report)

  • [Y] US 2004228830 A1 20041118 - HIRSH JANE [US], et al
  • [YD] US 2004106681 A1 20040603 - RAO SRINIVAS G [US], et al
  • [Y] US 2003232805 A1 20031218 - KRANZLER JAY D [US], et al
  • [Y] VITTON O ET AL: "A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia", HUMAN PSYCHOPHARMACOLOGY. CLINICAL AND EXPERIMENTAL, JOHN WILEY & SONS LTD, XX LNKD- DOI:10.1002/HUP.622, vol. 19, no. Suppl. 1, October 2004 (2004-10-01), pages S27 - S35, XP002587812, ISSN: 0885-6222, [retrieved on 20040920]

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

Designated extension state (EPC)

AL BA HR MK RS

DOCDB simple family (publication)

US 2007072946 A1 20070329; US 7994220 B2 20110809; AU 2006294645 A1 20070405; AU 2006294645 B2 20120823; BR PI0617541 A2 20110726; CA 2624018 A1 20070405; CN 101355930 A 20090128; CR 9882 A 20090327; EC SP088407 A 20080630; EP 1928446 A2 20080611; EP 1928446 A4 20100825; EP 2682114 A1 20140108; EP 2682114 B1 20201104; GE P20125595 B 20120810; IL 190284 A0 20090922; IL 190284 A 20140130; IL 228904 A0 20131231; IL 228904 A 20160831; JP 2009510080 A 20090312; JP 2012193216 A 20121011; JP 2015134811 A 20150727; JP 5922515 B2 20160524; JP 6014702 B2 20161025; KR 20080055967 A 20080619; MA 31720 B1 20101001; MY 145340 A 20120131; NI 200800099 A 20120817; NO 20081951 L 20080423; NZ 567271 A 20110630; NZ 593199 A 20121130; RU 2008112192 A 20091110; RU 2437661 C2 20111227; SG 10201706677T A 20170928; SG 10201807899P A 20181030; SG 183735 A1 20120927; SV 2008002855 A 20080630; TN SN08129 A1 20090714; UA 94721 C2 20110610; WO 2007038620 A2 20070405; WO 2007038620 A3 20071018; ZA 200803469 B 20090225

DOCDB simple family (application)

US 53523706 A 20060926; AU 2006294645 A 20060927; BR PI0617541 A 20060927; CA 2624018 A 20060927; CN 200680036203 A 20060927; CR 9882 A 20080411; EC SP088407 A 20080428; EP 06804211 A 20060927; EP 13187396 A 20060927; GE AP2006010664 A 20060927; IL 19028408 A 20080318; IL 22890413 A 20131016; JP 2008533575 A 20060927; JP 2012159397 A 20120718; JP 2015063053 A 20150325; KR 20087010241 A 20080428; MA 30872 A 20080424; MY PI20080895 A 20080328; NI 200800099 A 20080327; NO 20081951 A 20080423; NZ 56727106 A 20060927; NZ 59319906 A 20060927; RU 2008112192 A 20060927; SG 10201706677T A 20060927; SG 10201807899P A 20060927; SG 2012060638 A 20060927; SV 2008002855 A 20080328; TN SN08129 A 20080319; UA A200805524 A 20060927; US 2006037714 W 20060927; ZA 200803469 A 20080418